CS
Cannell & Spears Portfolio holdings
AUM
$4.95B
This Quarter Return
+1.99%
1 Year Return
+21.47%
3 Year Return
+82.49%
5 Year Return
+137.04%
10 Year Return
+287.57%
AUM
$903M
AUM Growth
+$903M
(+8.1%)
Cap. Flow
+$56.2M
Cap. Flow
% of AUM
6.23%
Top 10 Holdings %
Top 10 Hldgs %
45.8%
Holding
159
New
24
Increased
30
Reduced
51
Closed
17
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$25.9M |
| 2 |
CIT
CIT Group Inc.
CIT
|
$10.7M |
| 3 |
Citigroup
C
|
$10.6M |
| 4 |
Williams Companies
WMB
|
$8.42M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$3.93M |
Top Sells
Sector Composition
| 1 | Financials | 25.7% |
| 2 | Healthcare | 17.62% |
| 3 | Technology | 13.11% |
| 4 | Industrials | 12.75% |
| 5 | Energy | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Colgate-Palmolive
CL
$67.9B
| $410K | 0.05% |
6,266
| – | – |
|
102
US Bancorp
USB
$76B
| $397K | 0.04% |
+9,150
| New | +$397K |
|
103
Intel
INTC
$107B
| $385K | 0.04% |
12,664
| – | – |
|
104
Bristol-Myers Squibb
BMY
$96B
| $383K | 0.04% |
5,763
-1,800
| -24% | -$120K |
|
105
Franklin Resources
BEN
$13.3B
| $365K | 0.04% |
7,449
| – | – |
|
|
DD
106
DELISTED
Du Pont De Nemours E I
DD
| $360K | 0.04% |
5,632
-3,250
| -37% | -$208K |
|
107
Broadridge
BR
$29.9B
| $349K | 0.04% |
6,970
| – | – |
|
108
Pfizer
PFE
$141B
| $342K | 0.04% |
10,201
-76
| -0.7% | -$2.55K |
|
109
VF Corp
VFC
$5.91B
| $339K | 0.04% |
4,854
| – | – |
|
110
Goldman Sachs
GS
$226B
| $334K | 0.04% |
1,600
| – | – |
|
111
Emerson Electric
EMR
$74.3B
| $330K | 0.04% |
5,960
| – | – |
|
112
Invesco QQQ Trust
QQQ
$364B
| $316K | 0.04% |
2,950
| – | – |
|
113
iShares Expanded Tech-Software Sector ETF
IGV
$9.84B
| $306K | 0.03% |
3,080
-13,040
| -81% | -$1.3M |
|
114
Flowserve
FLS
$7.02B
| $305K | 0.03% |
+5,784
| New | +$305K |
|
115
iShares MSCI Global Gold Miners ETF
RING
$1.91B
| $284K | 0.03% |
39,750
| – | – |
|
116
Everest Group
EG
$14.3B
| $280K | 0.03% |
1,539
| – | – |
|
117
Pitney Bowes
PBI
$2.09B
| $276K | 0.03% |
+13,286
| New | +$276K |
|
118
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $275K | 0.03% |
+5,672
| New | +$275K |
|
119
GSK
GSK
$79.9B
| $266K | 0.03% |
6,384
+39
| +0.6% | +$1.63K |
|
120
KLA
KLAC
$115B
| $250K | 0.03% |
+4,442
| New | +$250K |
|
121
MDU Resources
MDU
$3.33B
| $250K | 0.03% |
+12,815
| New | +$250K |
|
122
United Airlines
UAL
$34B
| $247K | 0.03% |
+4,658
| New | +$247K |
|
123
Sherwin-Williams
SHW
$91.2B
| $246K | 0.03% |
896
| – | – |
|
124
Healthpeak Properties
DOC
$12.5B
| $245K | 0.03% |
+6,731
| New | +$245K |
|
125
EOG Resources
EOG
$68.2B
| $242K | 0.03% |
2,765
| – | – |
|